DRUG · Mapped RxNorm record
Rosiglitazone
Normalized identity: rosiglitazoneView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Free Fatty Acid-Induced Hypertension in Obese Subjects With Type 2 Diabetes
NCT00738023
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Normal saline 0.9%
Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
Intralipid 20%
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedFree Fatty Acid-Induced Hypertension in Obese Subjects With Type 2 Diabetes
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Hypertensionunresolved
Interventions
Sponsors & collaborators
Emory Universitylead sponsor
GlaxoSmithKlinecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00738023 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.